KENNY PEREZ: Open Payments
NPI 1730524307 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212,261 in 283 payments from 9 companies in 2025. Trend: 2023 $27,208 · 2024 $154,164 · 2025 $212,261
Speaker / faculty: $105,125Honoraria: $79,475Travel & lodging: $18,447Food & beverage: $5,555Consulting: $3,660
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 155 | $125,501 |
| Axsome Therapeutics, Inc. | 113 | $86,357 |
| Vanda Pharmaceuticals Inc. | 4 | $121 |
| Corium, LLC | 4 | $105 |
| E.R. Squibb & Sons, L.L.C. | 3 | $74 |
| ABBVIE INC. | 1 | $30 |
| Lundbeck LLC | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Alkermes, Inc. | 1 | $20 |
Products named: SPRAVATO, Auvelity, Azstarys, COBENFY, FANAPT, HETLIOZ, VRAYLAR, REXULTI.
Industry payments across FL — which companies pay providers there.
